Nearly no one got into the business of health care because they want to think about identity. But AI is making us all rethink healthcare, and quickly. And identity is
A Prescription for Drug Costs: Inject Transparency and Improve Accessibility
Drug research continues to churn out new advances, some that are potential cures. But even though more than $800 billion a year is spent on pharmaceuticals, many Americans either don’t
What Health Tech Investors Love in Founders — and What They Can’t Stand
Digital health investors have heard nearly every founder pitch imaginable, including many that start along the lines of “healthcare is broken, and I’m the one who’s going to fix it.”
Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail
Priority Health, a Michigan-based insurer, announced Wednesday that it has launched two new cancer support solutions for employers in partnership with Color Health and Grail. The insurer serves more than
CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO
For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a
Who Broke the Healthcare System?
It’s often said that the healthcare system is broken, from the outdated use of fax machines to perverse incentives. But who broke the healthcare system? At MedCity News’ Bullseye event
Rethinking How Hospitals Measure Behavioral Health Success
Two patients who present in the emergency department in identical ways can have very different treatment experiences, even if they’re both assessed within the standard window and discharged within the
Assured Health Secures $19M to Get Providers In-Network Faster with Agentic AI
Getting a new doctor approved to see patients and bill insurance often takes months — time that providers and patients don’t have. On Wednesday, a New York City-based startup raised
$10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval
A drug included in one of the pharmaceutical industry’s largest acquisitions this year is starting to paying dividends for GSK, winning a speedy regulatory nod that continues the pharmaceutical company’s
Hidden in Plain Sight: The Cost Crisis in Women’s Healthcare
Women’s health is one of the largest cost categories for employers, health plans, and third-party benefit administrators. When viewed holistically, it rivals cardiometabolic and musculoskeletal conditions and represents a significant









